About Novavax

Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...

Investors

Click here for Webcast

Ladenburg Healthcare Conference Presentation
Tuesday, September 26, 2017 @ 11:00 a.m. ET

NOVAVAX’ recombinant protein
nanoparticle vaccine technology

NOVAVAX’ maternal immunization
RSV vaccine candidate

NOVAVAX AWARDS